首页 > 最新文献

Hormone Molecular Biology and Clinical Investigation最新文献

英文 中文
Association of neutrophil gelatinase associated lipocalin, ischemia modified albumin with uric acid in the etiopathogenesis of preeclampsia. 中性粒细胞明胶酶相关脂钙蛋白、缺血修饰白蛋白与尿酸在子痫前期发病中的关系。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0012
Nitin Parasher, Priya Kaushik, Naveen Kumar Singh, Sweta, Lalit Yadav, Bibek Bhurer Yadav, Arpita Suri

Objectives: Preeclampsia is a multisystem illness that manifests in the third trimester of pregnancy after 20 weeks of gestation and is marked by proteinuria and hypertension (PE). Changes in lifestyle, such as eating a high-calorie diet and delaying delivery, have raised the likelihood of developing PE. Eclampsia, abrupt renal failure, thromboembolic episodes leading to cardiac and brain problems, pulmonary embolism, and coagulopathy associated with HELLP syndrome are a few of the complications that might follow preeclampsia in pregnant moms. The objects of this study is to estimate and correlate the levels of NGAL (neutrophil gelatinase associated lipocalin), IMA (ischemia modified albumin) and Uric acid in prreclampsia.

Methods: 40 diagnosed cases of preeclampsia and 40 healthy age and gestational age matched healthy controls were included in the study. Blood samples were collected from them and serum NGAL, IMA and Uric acid levels were estimated. Estimation of NGAL (neutrophil gelatinase associated lipocalin), IMA (ischemia modified albumin) was done by commercially available ELISA kits standard spectrophotometry methods in autoanalyzer Mind ray BS300 using commercially available kits.

Results: The parameters of NGAL and IMA were significantly increased in patients with PE (p<0.001) when compared with the healthy control subjects. γ-glutamyl transferases and OPN were found in patients with ALD (p<0.001) when compared with the control subjects. OPN showed significant positive correlations with AST (r=0.76, p<0.001), ALT (r=0.64 p<0.001), ALP (r=0.68, p<0.001), and GGT (r=0.61, p<0.001).

Conclusions: The current study focuses on the roles of NGAL and IMA, two sensitive markers of kidney injury that are particularly useful in identifying widespread endothelial dysfunction. As a result, the pattern of elevated NGAL and IMA levels can be useful for diagnosis.

目的:子痫前期是一种多系统疾病,表现在妊娠20周后的妊娠晚期,以蛋白尿和高血压(PE)为特征。生活方式的改变,如高热量饮食和推迟分娩,都增加了患PE的可能性。子痫、突发性肾衰竭、导致心脏和大脑问题的血栓栓塞发作、肺栓塞和HELLP综合征相关的凝血功能障碍是孕妇子痫前期可能出现的一些并发症。本研究的目的是估计和关联NGAL(中性粒细胞明胶酶相关脂钙蛋白),IMA(缺血修饰白蛋白)和尿酸在钳死前的水平。方法:选取40例确诊的先兆子痫患者和40例健康年龄及胎龄匹配的健康对照。采集他们的血样,评估血清NGAL、IMA和尿酸水平。NGAL(中性粒细胞明胶酶相关脂钙蛋白)、IMA(缺血修饰白蛋白)的测定采用市售ELISA试剂盒,全自动分析仪Mind ray BS300使用市售试剂盒进行标准分光光度法测定。结果:NGAL和IMA的参数在PE患者中显著升高(结论:目前的研究重点是NGAL和IMA的作用,这两个敏感的肾损伤标志物在识别广泛的内皮功能障碍方面特别有用。因此,NGAL和IMA水平升高的模式可用于诊断。
{"title":"Association of neutrophil gelatinase associated lipocalin, ischemia modified albumin with uric acid in the etiopathogenesis of preeclampsia.","authors":"Nitin Parasher,&nbsp;Priya Kaushik,&nbsp;Naveen Kumar Singh,&nbsp;Sweta,&nbsp;Lalit Yadav,&nbsp;Bibek Bhurer Yadav,&nbsp;Arpita Suri","doi":"10.1515/hmbci-2022-0012","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0012","url":null,"abstract":"<p><strong>Objectives: </strong>Preeclampsia is a multisystem illness that manifests in the third trimester of pregnancy after 20 weeks of gestation and is marked by proteinuria and hypertension (PE). Changes in lifestyle, such as eating a high-calorie diet and delaying delivery, have raised the likelihood of developing PE. Eclampsia, abrupt renal failure, thromboembolic episodes leading to cardiac and brain problems, pulmonary embolism, and coagulopathy associated with HELLP syndrome are a few of the complications that might follow preeclampsia in pregnant moms. The objects of this study is to estimate and correlate the levels of NGAL (neutrophil gelatinase associated lipocalin), IMA (ischemia modified albumin) and Uric acid in prreclampsia.</p><p><strong>Methods: </strong>40 diagnosed cases of preeclampsia and 40 healthy age and gestational age matched healthy controls were included in the study. Blood samples were collected from them and serum NGAL, IMA and Uric acid levels were estimated. Estimation of NGAL (neutrophil gelatinase associated lipocalin), IMA (ischemia modified albumin) was done by commercially available ELISA kits standard spectrophotometry methods in autoanalyzer Mind ray BS300 using commercially available kits.</p><p><strong>Results: </strong>The parameters of NGAL and IMA were significantly increased in patients with PE (p<0.001) when compared with the healthy control subjects. γ-glutamyl transferases and OPN were found in patients with ALD (p<0.001) when compared with the control subjects. OPN showed significant positive correlations with AST (r=0.76, p<0.001), ALT (r=0.64 p<0.001), ALP (r=0.68, p<0.001), and GGT (r=0.61, p<0.001).</p><p><strong>Conclusions: </strong>The current study focuses on the roles of NGAL and IMA, two sensitive markers of kidney injury that are particularly useful in identifying widespread endothelial dysfunction. As a result, the pattern of elevated NGAL and IMA levels can be useful for diagnosis.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9202380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
COVID-19: a viewpoint from hepatic perspective. 从肝脏角度看COVID-19。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0026
Abhijeet Brizawasi, Ashok Kumar Ahirwar, Prabhat, Kirti Kaim, Pradeep Ahirwar, Rajani Kumawat, Jitender Prasad

Coronaviruses as such are known since last century. The name is derived from their shape which has crown (corona) like radiating spikes. The recent one however is a different one from the Coronavirus involved in SARS (2002-2004) and MERS (2012) in being highly infectious. Initially COVID 19 had a high case fatality rate which has now decreased to a significant extent. Many cases of COVID 19 are asymptomatic with a significant number of positive cases developing a triad of fever, breathlessness and GI symptoms. Recent travel increases the probability of infection. The pathogenesis involves ACE 2 receptors. So, it has been found that there are more cases and mortality among hypertensive individuals. Even higher among the people who use ACE inhibitor in comparison to those who use other anti-hypertensive drugs. Treatment is usually symptomatic. Antiviral drugs and vaccines against COVID-19 are being used. Deranged liver enzymes are common in COVID-19, however, serious liver injury is not much documented. Liver injury is either due to disease itself or due to antiviral drugs. Extra care like strict social distancing, avoiding unnecessary contact is needed for those with autoimmune hepatitis, liver cancer and those who are in immunosuppression because of a scheduled or already liver transplant. Further research is definitely needed in this field. The upcoming researches should also focus on liver injuries associated with disease course and derangements arising as side effects of treatment of COVID-19.

冠状病毒自上个世纪以来就为人所知。这个名字来源于它们的形状,有冠(日冕)像辐射的尖刺。然而,最近的冠状病毒与SARS(2002-2004年)和MERS(2012年)中的冠状病毒不同,传染性很强。最初,COVID - 19的病死率很高,现在已经大幅下降。许多COVID - 19病例无症状,大量阳性病例出现发烧、呼吸困难和胃肠道症状。最近的旅行增加了感染的可能性。其发病机制与ACE 2受体有关。因此,高血压患者的发病率和死亡率更高。与使用其他抗高血压药物的人相比,使用ACE抑制剂的人甚至更高。治疗通常是有症状的。目前正在使用针对COVID-19的抗病毒药物和疫苗。肝酶紊乱在COVID-19中很常见,但严重的肝损伤并没有太多记录。肝损伤要么是由于疾病本身,要么是由于抗病毒药物。对于那些患有自身免疫性肝炎、肝癌以及因计划或已经进行肝移植而处于免疫抑制状态的人来说,需要额外的照顾,比如严格的社交距离,避免不必要的接触。这一领域还需要进一步的研究。今后的研究也应该集中在与病程相关的肝损伤和治疗副作用引起的紊乱上。
{"title":"COVID-19: a viewpoint from hepatic perspective.","authors":"Abhijeet Brizawasi,&nbsp;Ashok Kumar Ahirwar,&nbsp;Prabhat,&nbsp;Kirti Kaim,&nbsp;Pradeep Ahirwar,&nbsp;Rajani Kumawat,&nbsp;Jitender Prasad","doi":"10.1515/hmbci-2022-0026","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0026","url":null,"abstract":"<p><p>Coronaviruses as such are known since last century. The name is derived from their shape which has crown (corona) like radiating spikes. The recent one however is a different one from the Coronavirus involved in SARS (2002-2004) and MERS (2012) in being highly infectious. Initially COVID 19 had a high case fatality rate which has now decreased to a significant extent. Many cases of COVID 19 are asymptomatic with a significant number of positive cases developing a triad of fever, breathlessness and GI symptoms. Recent travel increases the probability of infection. The pathogenesis involves ACE 2 receptors. So, it has been found that there are more cases and mortality among hypertensive individuals. Even higher among the people who use ACE inhibitor in comparison to those who use other anti-hypertensive drugs. Treatment is usually symptomatic. Antiviral drugs and vaccines against COVID-19 are being used. Deranged liver enzymes are common in COVID-19, however, serious liver injury is not much documented. Liver injury is either due to disease itself or due to antiviral drugs. Extra care like strict social distancing, avoiding unnecessary contact is needed for those with autoimmune hepatitis, liver cancer and those who are in immunosuppression because of a scheduled or already liver transplant. Further research is definitely needed in this field. The upcoming researches should also focus on liver injuries associated with disease course and derangements arising as side effects of treatment of COVID-19.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9208539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anti-proliferation effects of Apatinib in combination with Curcumin in breast cancer cells. 阿帕替尼联合姜黄素对乳腺癌细胞的抗增殖作用。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0036
Mahdi Farhoudi Sefidan Jadid, Gholamreza Jahangirzadehd, Javad Behroozi

Objectives: Despite remarkable development of new therapeutic strategies to improve survival rates and treatment of patients with cancer, there are still many limitations in management of patients with distant metastasis breast cancer. Therefore, the aim of this study was to investigate a novel method to enhance therapeutic efficacy of Apatinib (as a chemotherapeutic agent) by co-administration of Curcumin (as a bioactive herbal compound) in breast cancer treatment.

Methods: Effects of Apatinib, Curcumin, and their combinations (Apa-Cur) was evaluated on viability and proliferation of breast cell line (MCF7) by MTT assay. Moreover, effects of Apatinib, Curcumin, and Apa-Cur was investigated on apoptosis rate in the cancer cells. Expression levels of apoptosis-related genes (BAX, SMAC, BCL2, and SURVIVIN) in treated cancer cells and untreated controls were evaluated using the Real-Time PCR method.

Results: The obtained results showed that all treatments of Apatinib, Curcumin, and Apa-Cur significantly decreased viability and proliferation of the breast cancer cells in a concentration- and time-dependent manner. However, anti-proliferation activity of Apa-Cur combination was significantly higher than Apatinib and Curcumin treatment alone. In addition, Apatinib, Curcumin, and Apa-Cur increased apoptosis percentage in the treated cancer cells through regulation of apoptosis-related genes expression.

Conclusions: In general, Apa-Cur combination therapy exerts more profound anti-proliferation effects on breast cancer cell than Apatinib or Curcumin monotherapy. However, further studies are required to identify other possible signaling pathways and mechanisms involved in the anticancer effects of Apatinib, Curcumin, and Apa-Cur.

目的:尽管新的治疗策略在提高癌症患者的生存率和治疗方面取得了显著进展,但在远处转移性乳腺癌患者的治疗方面仍存在许多局限性。因此,本研究的目的是探索一种新的方法,通过与姜黄素(一种生物活性草药化合物)共同给药来提高阿帕替尼(作为化疗药物)在乳腺癌治疗中的疗效。方法:采用MTT法观察阿帕替尼、姜黄素及其联合用药(Apa-Cur)对乳腺癌MCF7细胞活力和增殖的影响。此外,我们还研究了阿帕替尼、姜黄素和Apa-Cur对肿瘤细胞凋亡率的影响。使用Real-Time PCR方法评估处理过的癌细胞和未处理的对照组中凋亡相关基因(BAX、SMAC、BCL2和SURVIVIN)的表达水平。结果:得到的结果显示,阿帕替尼、姜黄素和Apa-Cur处理均能显著降低乳腺癌细胞的活力和增殖,且呈浓度依赖性和时间依赖性。然而,Apa-Cur联合治疗的抗增殖活性明显高于阿帕替尼和姜黄素单独治疗。此外,阿帕替尼、姜黄素和Apa-Cur通过调节凋亡相关基因的表达,增加了治疗后癌细胞的凋亡百分比。结论:总的来说,阿帕替尼和姜黄素联合治疗对乳腺癌细胞的抗增殖作用比阿帕替尼或姜黄素单药更深刻。然而,需要进一步的研究来确定阿帕替尼、姜黄素和Apa-Cur抗癌作用中涉及的其他可能的信号通路和机制。
{"title":"Anti-proliferation effects of Apatinib in combination with Curcumin in breast cancer cells.","authors":"Mahdi Farhoudi Sefidan Jadid,&nbsp;Gholamreza Jahangirzadehd,&nbsp;Javad Behroozi","doi":"10.1515/hmbci-2022-0036","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0036","url":null,"abstract":"<p><strong>Objectives: </strong>Despite remarkable development of new therapeutic strategies to improve survival rates and treatment of patients with cancer, there are still many limitations in management of patients with distant metastasis breast cancer. Therefore, the aim of this study was to investigate a novel method to enhance therapeutic efficacy of Apatinib (as a chemotherapeutic agent) by co-administration of Curcumin (as a bioactive herbal compound) in breast cancer treatment.</p><p><strong>Methods: </strong>Effects of Apatinib, Curcumin, and their combinations (Apa-Cur) was evaluated on viability and proliferation of breast cell line (MCF7) by MTT assay. Moreover, effects of Apatinib, Curcumin, and Apa-Cur was investigated on apoptosis rate in the cancer cells. Expression levels of apoptosis-related genes (<i>BAX</i>, <i>SMAC</i>, <i>BCL2</i>, and <i>SURVIVIN</i>) in treated cancer cells and untreated controls were evaluated using the Real-Time PCR method.</p><p><strong>Results: </strong>The obtained results showed that all treatments of Apatinib, Curcumin, and Apa-Cur significantly decreased viability and proliferation of the breast cancer cells in a concentration- and time-dependent manner. However, anti-proliferation activity of Apa-Cur combination was significantly higher than Apatinib and Curcumin treatment alone. In addition, Apatinib, Curcumin, and Apa-Cur increased apoptosis percentage in the treated cancer cells through regulation of apoptosis-related genes expression.</p><p><strong>Conclusions: </strong>In general, Apa-Cur combination therapy exerts more profound anti-proliferation effects on breast cancer cell than Apatinib or Curcumin monotherapy. However, further studies are required to identify other possible signaling pathways and mechanisms involved in the anticancer effects of Apatinib, Curcumin, and Apa-Cur.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9562087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients. nf -γ作为免疫愈合标志物在糖尿病和非糖尿病肺结核患者抗结核治疗中的比较评价。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0031
Birendra Kumar Yadav, Ashok Kumar Shah, Busi Karunanand, Dharampal Singh Sudan, Monika Sharma

Objectives: Tuberculosis is an infectious airborne disease caused by Mycobacterium tuberculosis. Pulmonary tuberculosis is the ninth most frequent complication of diabetes mellitus. The co-existence of TB and DM in patient causes severe TB symptoms, modify radiological findings, slower response to treatment outcomes and prognosis. IFN-γ is the key cytokine which play role in the protective immune response against mycobacterium infection. The main function of IFN-γ is macrophage activation which is able to exert its microbicidal functions. Estimation and comparison of pre and post treatment serum IFN-γ among pulmonary tuberculosis among diabetic and non-diabetic patients.

Methods: The study was conducted in the Departments of Biochemistry and Pulmonary Medicine, FMHS, SGT University, Budhera, Gurugram and District TB Centre, Gurugram, Haryana, India. In this study, 100 newly diagnosed PTB patients without diabetes mellitus and 100 newly diagnosed PTB patients with diabetes mellitus (PTB-DM) above 15 years of age were included after obtaining written consent. 5 mL venous blood was collected from patients of pre and post anti-tubercular treatment. The level of IFN-γ was measured by ELISA method.

Results: The circulating level of IFN-γ in PTB patients was significantly decreased in post-treatment (25.53 ± 6.12 pg/mL) compared to pre-treatment (58.76 ± 16.02 pg/mL) with t-value 32.03 and p-value <0.001. The circulating level of IFN-γ in PTB-DM patients was significantly decreased in post treatment (29.11 ± 7.41 pg/mL) compared to pre-treatment (44.14 ± 10.85 pg/mL) with t-value 31.35 and p-value <0.001. In the present study, level of IFN-γ in pre-treatment PTB patients (58.76 ± 16.02 pg/mL) was significantly raised compared to PTB-DM patients (44.14 ± 10.85 pg/mL) with t-value 7.55 and p-value <0.001. However, level of IFN-γ in post-treatment PTB patients (25.53 ± 6.12 pg/mL) was significantly low compared to PTB-DM patients (29.11 ± 7.41 pg/mL) with t-value 3.71 and p-value <0.001.

Conclusions: The decreased level of IFN-γ in post-treatment compared to pre-treatment in both PTB and PTB-DM patients had shown efficacy of anti-tubercular treatment. However, the post treatment level of IFN-γ was high in PTB-DM patients compared to PTB patients which verified that effect of ATT was low in PTB-DM.

目的:结核病是由结核分枝杆菌引起的一种空气传播传染病。肺结核是糖尿病的第九大常见并发症。患者结核和糖尿病的共存导致严重的结核症状,改变放射学表现,对治疗结果和预后的反应较慢。IFN-γ是在抗分枝杆菌感染的保护性免疫应答中起关键作用的细胞因子。IFN-γ的主要功能是激活巨噬细胞,从而发挥其杀灭微生物的功能。糖尿病与非糖尿病肺结核患者治疗前后血清IFN-γ的测定与比较方法:研究在印度哈里亚纳邦古尔格拉姆省布德拉市SGT大学FMHS生物化学系和肺医学系以及古尔格拉姆地区结核病中心进行。本研究纳入100例新诊断的无糖尿病PTB患者和100例15岁以上新诊断的PTB合并糖尿病(PTB- dm)患者,经书面同意。采集抗结核治疗前后患者静脉血5 mL。ELISA法检测IFN-γ水平。结果:PTB患者治疗后血清IFN-γ水平较治疗前(58.76±16.02 pg/mL)显著降低(25.53±6.12 pg/mL), t值为32.03,p值为p值。结论:PTB和PTB- dm患者治疗后血清IFN-γ水平较治疗前明显降低,显示出抗结核治疗的效果。然而,与PTB患者相比,PTB- dm患者治疗后的IFN-γ水平较高,这证实了ATT对PTB- dm的影响较低。
{"title":"Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients.","authors":"Birendra Kumar Yadav,&nbsp;Ashok Kumar Shah,&nbsp;Busi Karunanand,&nbsp;Dharampal Singh Sudan,&nbsp;Monika Sharma","doi":"10.1515/hmbci-2022-0031","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0031","url":null,"abstract":"<p><strong>Objectives: </strong>Tuberculosis is an infectious airborne disease caused by <i>Mycobacterium tuberculosis</i>. Pulmonary tuberculosis is the ninth most frequent complication of diabetes mellitus. The co-existence of TB and DM in patient causes severe TB symptoms, modify radiological findings, slower response to treatment outcomes and prognosis. IFN-γ is the key cytokine which play role in the protective immune response against mycobacterium infection. The main function of IFN-γ is macrophage activation which is able to exert its microbicidal functions. Estimation and comparison of pre and post treatment serum IFN-γ among pulmonary tuberculosis among diabetic and non-diabetic patients.</p><p><strong>Methods: </strong>The study was conducted in the Departments of Biochemistry and Pulmonary Medicine, FMHS, SGT University, Budhera, Gurugram and District TB Centre, Gurugram, Haryana, India. In this study, 100 newly diagnosed PTB patients without diabetes mellitus and 100 newly diagnosed PTB patients with diabetes mellitus (PTB-DM) above 15 years of age were included after obtaining written consent. 5 mL venous blood was collected from patients of pre and post anti-tubercular treatment. The level of IFN-γ was measured by ELISA method.</p><p><strong>Results: </strong>The circulating level of IFN-γ in PTB patients was significantly decreased in post-treatment (25.53 ± 6.12 pg/mL) compared to pre-treatment (58.76 ± 16.02 pg/mL) with t-value 32.03 and p-value <0.001. The circulating level of IFN-γ in PTB-DM patients was significantly decreased in post treatment (29.11 ± 7.41 pg/mL) compared to pre-treatment (44.14 ± 10.85 pg/mL) with t-value 31.35 and p-value <0.001. In the present study, level of IFN-γ in pre-treatment PTB patients (58.76 ± 16.02 pg/mL) was significantly raised compared to PTB-DM patients (44.14 ± 10.85 pg/mL) with t-value 7.55 and p-value <0.001. However, level of IFN-γ in post-treatment PTB patients (25.53 ± 6.12 pg/mL) was significantly low compared to PTB-DM patients (29.11 ± 7.41 pg/mL) with t-value 3.71 and p-value <0.001.</p><p><strong>Conclusions: </strong>The decreased level of IFN-γ in post-treatment compared to pre-treatment in both PTB and PTB-DM patients had shown efficacy of anti-tubercular treatment. However, the post treatment level of IFN-γ was high in PTB-DM patients compared to PTB patients which verified that effect of ATT was low in PTB-DM.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9208532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Potential role of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome. 内质网应激在多囊卵巢综合征病理生理中的潜在作用。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0051
Beatriz Alexandre-Santos, Felipe Figuerôa Tassinari Rocha Martins, Larissa da Silva Gonçalves, Clara de Oliveira Guimarães, Fernanda Carla-Ruggiero, D'Angelo Carlo Magliano

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects million women worldwide, presenting a complex pathophysiology that has not been fully elucidated yet. Recently, it has been suggested that PCOS triggers the endoplasmic reticulum (ER) stress, thus being associated with unfolded protein response (UPR) activation. Indeed, the UPR response has been associated with several pathological conditions, including in the reproductive system. Several studies demonstrated that ovarian UPR markers are upregulated in PCOS, being associated with worst ovarian outcomes, and this was ameliorated by ER stress inhibition. In this review, we aim to summarize the main findings from previous studies covering this topic, in an attempt to clarify the potential role of ER stress and the UPR response in the pathophysiology of PCOS.

多囊卵巢综合征(PCOS)是一种影响全球数百万女性的内分泌疾病,其复杂的病理生理机制尚未完全阐明。近年来,有研究认为多囊卵巢综合征触发内质网应激,从而与未折叠蛋白反应(UPR)激活有关。事实上,普遍定期审议反应与包括生殖系统在内的几种病理状况有关。一些研究表明,卵巢UPR标志物在PCOS中上调,与卵巢预后最差有关,内质网应激抑制可改善这种情况。在本文中,我们旨在总结这一主题的主要研究成果,试图阐明内质网应激和UPR反应在多囊卵巢综合征病理生理中的潜在作用。
{"title":"Potential role of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome.","authors":"Beatriz Alexandre-Santos,&nbsp;Felipe Figuerôa Tassinari Rocha Martins,&nbsp;Larissa da Silva Gonçalves,&nbsp;Clara de Oliveira Guimarães,&nbsp;Fernanda Carla-Ruggiero,&nbsp;D'Angelo Carlo Magliano","doi":"10.1515/hmbci-2022-0051","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0051","url":null,"abstract":"<p><p>Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects million women worldwide, presenting a complex pathophysiology that has not been fully elucidated yet. Recently, it has been suggested that PCOS triggers the endoplasmic reticulum (ER) stress, thus being associated with unfolded protein response (UPR) activation. Indeed, the UPR response has been associated with several pathological conditions, including in the reproductive system. Several studies demonstrated that ovarian UPR markers are upregulated in PCOS, being associated with worst ovarian outcomes, and this was ameliorated by ER stress inhibition. In this review, we aim to summarize the main findings from previous studies covering this topic, in an attempt to clarify the potential role of ER stress and the UPR response in the pathophysiology of PCOS.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9209906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyrotropin and body mass index, are they related? 促甲状腺激素和体重指数有关系吗?
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0002
Catarina R Ivo, Vitória Duarte, David Veríssimo, João Silva, Dolores Passos, Luís Lopes, João Jácome de Castro, Mafalda Marcelino

Objectives: It is well recognized that overt thyroid dysfunction is associated with changes in body mass index (BMI). However, there is ongoing debate regarding the influence of thyroid stimulating hormone (TSH) on BMI, in euthyroid subjects. The aim of this study is to examine the association of TSH with BMI in an outpatient population without evidence of thyroid disease.

Methods: Cross-sectional study conducted in an Endocrinology Department. We identified the latest TSH and BMI measurements in 923 patients from the reference euthyroid population. All patients with positive thyroid autoimmunity and nodules were excluded. We performed a linear regression analysis using SPSSv.025.

Results: 923 adult patients were evaluated. 79.4% were males, with a mean age of 67.6 years old. Mean TSH level was 1.78 mIU/L and mean BMI was 29.2 kg/m2. A significant negative correlation between serum TSH concentration and BMI was evident (p=0.04; r=-0.067). Statistical significance was lost when performing subgroup analysis, for males and females (p=0.19 and p=0.075), elderly (≥65 years) and non-elderly (p=0.55 and p=0.32) and also obese (BMI ≥30 kg/m2) and non-obese (p=0.39 and p=0.13).

Conclusions: The relationship between BMI and TSH is not consensual in the literature. This study included a large cohort sample of euthyroid patients, majority men and with negative autoimmunity. Our results support the hypothesis that variation in thyroid status within the normal range, could have a negative effect on BMI, contrary to most published studies.

目的:众所周知,明显的甲状腺功能障碍与身体质量指数(BMI)的变化有关。然而,在甲状腺功能正常的受试者中,关于促甲状腺激素(TSH)对BMI的影响一直存在争议。本研究的目的是在没有甲状腺疾病证据的门诊人群中检查TSH与BMI的关系。方法:横断面研究在内分泌科进行。我们确定了923例参考甲状腺功能正常人群的最新TSH和BMI测量值。排除所有甲状腺自身免疫阳性和结节的患者。我们使用SPSSv.025进行线性回归分析。结果:对923例成人患者进行了评价。79.4%为男性,平均年龄67.6岁。平均TSH水平为1.78 mIU/L,平均BMI为29.2 kg/m2。血清TSH浓度与BMI呈显著负相关(p=0.04;r = -0.067)。在进行亚组分析时,男性和女性(p=0.19和p=0.075)、老年人(≥65岁)和非老年人(p=0.55和p=0.32)、肥胖(BMI≥30 kg/m2)和非肥胖(p=0.39和p=0.13)均无统计学意义。结论:BMI和TSH之间的关系在文献中并不是双方同意的。本研究纳入了大量甲状腺功能正常患者的队列样本,大多数为男性,自身免疫阴性。我们的研究结果支持了一个假设,即甲状腺状态在正常范围内的变化可能会对BMI产生负面影响,这与大多数已发表的研究相反。
{"title":"Thyrotropin and body mass index, are they related?","authors":"Catarina R Ivo,&nbsp;Vitória Duarte,&nbsp;David Veríssimo,&nbsp;João Silva,&nbsp;Dolores Passos,&nbsp;Luís Lopes,&nbsp;João Jácome de Castro,&nbsp;Mafalda Marcelino","doi":"10.1515/hmbci-2022-0002","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0002","url":null,"abstract":"<p><strong>Objectives: </strong>It is well recognized that overt thyroid dysfunction is associated with changes in body mass index (BMI). However, there is ongoing debate regarding the influence of thyroid stimulating hormone (TSH) on BMI, in euthyroid subjects. The aim of this study is to examine the association of TSH with BMI in an outpatient population without evidence of thyroid disease.</p><p><strong>Methods: </strong>Cross-sectional study conducted in an Endocrinology Department. We identified the latest TSH and BMI measurements in 923 patients from the reference euthyroid population. All patients with positive thyroid autoimmunity and nodules were excluded. We performed a linear regression analysis using SPSSv.025.</p><p><strong>Results: </strong>923 adult patients were evaluated. 79.4% were males, with a mean age of 67.6 years old. Mean TSH level was 1.78 mIU/L and mean BMI was 29.2 kg/m<sup>2</sup>. A significant negative correlation between serum TSH concentration and BMI was evident (p=0.04; r=-0.067). Statistical significance was lost when performing subgroup analysis, for males and females (p=0.19 and p=0.075), elderly (≥65 years) and non-elderly (p<i>=</i>0.55 and p<i>=</i>0.32) and also obese (BMI ≥30 kg/m<sup>2</sup>) and non-obese (p=0.39 and p=0.13)<i>.</i></p><p><strong>Conclusions: </strong>The relationship between BMI and TSH is not consensual in the literature. This study included a large cohort sample of euthyroid patients, majority men and with negative autoimmunity. Our results support the hypothesis that variation in thyroid status within the normal range, could have a negative effect on BMI, contrary to most published studies.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9208067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Modulatory role of prolactin in type 1 diabetes. 催乳素在1型糖尿病中的调节作用。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0008
Edgar Ramos-Martínez, Ivan Ramos-Martínez, Jorge Valencia, Juan Carlos Ramos-Martínez, Luis Hernández-Zimbrón, Anaiza Rico-Luna, Eduardo Pérez-Campos, Laura Pérez-Campos Mayoral, Marco Cerbón

Objectives: Patients with type 1 diabetes mellitus have been reported to have elevated prolactin levels and a possible relationship between prolactin levels and the development of the disease has been proposed. However, some studies show that prolactin mediates beneficial functions in beta cells. Therefore, we review information on the roles of prolactin in type 1 diabetes mellitus.

Content: Here we summarize the functions of prolactin in the immune system and in pancreatic beta cells, in addition, we describe studies related to PRL levels, its regulation and alterations of secretion in patients with type 1 diabetes mellitus.

Summary: Studies in murine models have shown that prolactin protects beta cells from apoptosis, stimulates their proliferation and promotes pancreatic islet revascularization. In addition, some studies in patients with type 1 diabetes mellitus have shown that elevated prolactin levels correlate with better disease control.

Outlook: Prolactin treatment appears to be a promising strategy to improve beta-cell vascularization and proliferation in transplantation and immunotherapies.

目的:已报道1型糖尿病患者催乳素水平升高,并提出催乳素水平与疾病发展之间可能存在的关系。然而,一些研究表明,催乳素介导β细胞的有益功能。因此,我们对催乳素在1型糖尿病中的作用进行综述。内容:本文综述了催乳素在免疫系统和胰腺β细胞中的功能,并对1型糖尿病患者催乳素水平、调节及分泌改变的相关研究进行了综述。摘要:小鼠模型研究表明,催乳素可保护β细胞免于凋亡,刺激其增殖并促进胰岛血运重建。此外,一些对1型糖尿病患者的研究表明,催乳素水平升高与更好的疾病控制有关。展望:在移植和免疫治疗中,催乳素治疗似乎是一种有希望改善β细胞血管化和增殖的策略。
{"title":"Modulatory role of prolactin in type 1 diabetes.","authors":"Edgar Ramos-Martínez,&nbsp;Ivan Ramos-Martínez,&nbsp;Jorge Valencia,&nbsp;Juan Carlos Ramos-Martínez,&nbsp;Luis Hernández-Zimbrón,&nbsp;Anaiza Rico-Luna,&nbsp;Eduardo Pérez-Campos,&nbsp;Laura Pérez-Campos Mayoral,&nbsp;Marco Cerbón","doi":"10.1515/hmbci-2022-0008","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0008","url":null,"abstract":"<p><strong>Objectives: </strong>Patients with type 1 diabetes mellitus have been reported to have elevated prolactin levels and a possible relationship between prolactin levels and the development of the disease has been proposed. However, some studies show that prolactin mediates beneficial functions in beta cells. Therefore, we review information on the roles of prolactin in type 1 diabetes mellitus.</p><p><strong>Content: </strong>Here we summarize the functions of prolactin in the immune system and in pancreatic beta cells, in addition, we describe studies related to PRL levels, its regulation and alterations of secretion in patients with type 1 diabetes mellitus.</p><p><strong>Summary: </strong>Studies in murine models have shown that prolactin protects beta cells from apoptosis, stimulates their proliferation and promotes pancreatic islet revascularization. In addition, some studies in patients with type 1 diabetes mellitus have shown that elevated prolactin levels correlate with better disease control.</p><p><strong>Outlook: </strong>Prolactin treatment appears to be a promising strategy to improve beta-cell vascularization and proliferation in transplantation and immunotherapies.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9214442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene polymorphism of leptin and risk for heart disease, obesity, and high BMI: a systematic review and pooled analysis in adult obese subjects. 瘦素基因多态性与心脏病、肥胖和高BMI风险:成人肥胖受试者的系统回顾和汇总分析
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0020
Fatemeh Khaki-Khatibi, Behrouz Shademan, Reza Gholikhani-Darbroud, Alireza Nourazarian, Saeed Radagdam, Maghsoud Porzour

Objectives: Leptin polymorphism (LEP) has been associated with coronary heart disease (CAD), obesity, and high body mass index (BMI). However, we performed a systematic review and meta-analysis to discover the association because previous studies reached different conclusions.

Methods: Review Manager, version 5.3.5, and Stata, version 15.0, were used for statistical analysis. We calculated the effect size of the studies using the OR with the corresponding 95% CI, and two-sided (bilateral) p-values of 0.05 were considered significant. To determine heterogeneity among the selected studies, the Q test and I2 statistics were used. Meta-regression was used to examine the disease (heart disease, obesity, and high BMI) and heterogeneity between these subgroups.

Results: Eleven studies with 18,984 subjects were included in this study. The G-2548A (rs12112075), rs7799039, and A19G (rs2167270) polymorphisms of the leptin gene (but not the Lys656Asn (rs1805094) polymorphism) are associated with an increased risk of cardiovascular disease. Our pooled analysis revealed an association between the G-2548A (rs12112075) polymorphism and heart disease, high BMI, and obesity. This indicates that individuals carrying the AA allele are at an increased risk for heart disease, high BMI, and obesity. People with heart failure and coronary artery disease did not have the rs7799039 polymorphism or its alleles linked to them.

Conclusions: Combined analysis of data from current and published research suggests that the leptin gene polymorphisms G-2548A (rs12112075), rs7799039, and A19G (rs2167270) (but not the Lys656Asn (rs1805094) polymorphism) are associated with an increased risk of cardiovascular disease. Further research is needed to understand this association.

目的:瘦素多态性(LEP)与冠心病(CAD)、肥胖和高体重指数(BMI)相关。然而,由于之前的研究得出了不同的结论,我们进行了系统回顾和荟萃分析来发现这种关联。方法:采用Review Manager软件5.3.5版本,Stata软件15.0版本进行统计分析。我们使用OR和相应的95% CI计算研究的效应大小,双侧(双侧)p值0.05被认为是显著的。为了确定所选研究之间的异质性,使用Q检验和I2统计。meta回归用于检查疾病(心脏病、肥胖和高BMI)和这些亚组之间的异质性。结果:本研究共纳入11项研究,共18,984名受试者。瘦素基因的G-2548A (rs12112075)、rs7799039和A19G (rs2167270)多态性(而不是Lys656Asn (rs1805094)多态性)与心血管疾病风险增加相关。我们的汇总分析显示G-2548A (rs12112075)多态性与心脏病、高BMI和肥胖之间存在关联。这表明携带AA等位基因的人患心脏病、高BMI和肥胖的风险更高。患有心力衰竭和冠状动脉疾病的人没有rs7799039多态性或与其相关的等位基因。结论:当前和已发表研究数据的综合分析表明,瘦素基因多态性G-2548A (rs12112075)、rs7799039和A19G (rs2167270)(而不是Lys656Asn (rs1805094)多态性)与心血管疾病风险增加相关。需要进一步的研究来理解这种联系。
{"title":"Gene polymorphism of leptin and risk for heart disease, obesity, and high BMI: a systematic review and pooled analysis in adult obese subjects.","authors":"Fatemeh Khaki-Khatibi,&nbsp;Behrouz Shademan,&nbsp;Reza Gholikhani-Darbroud,&nbsp;Alireza Nourazarian,&nbsp;Saeed Radagdam,&nbsp;Maghsoud Porzour","doi":"10.1515/hmbci-2022-0020","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0020","url":null,"abstract":"<p><strong>Objectives: </strong>Leptin polymorphism (LEP) has been associated with coronary heart disease (CAD), obesity, and high body mass index (BMI). However, we performed a systematic review and meta-analysis to discover the association because previous studies reached different conclusions.</p><p><strong>Methods: </strong>Review Manager, version 5.3.5, and Stata, version 15.0, were used for statistical analysis. We calculated the effect size of the studies using the OR with the corresponding 95% CI, and two-sided (bilateral) p-values of 0.05 were considered significant. To determine heterogeneity among the selected studies, the Q test and I2 statistics were used. Meta-regression was used to examine the disease (heart disease, obesity, and high BMI) and heterogeneity between these subgroups.</p><p><strong>Results: </strong>Eleven studies with 18,984 subjects were included in this study. The G-2548A (rs12112075), rs7799039, and A19G (rs2167270) polymorphisms of the leptin gene (but not the Lys656Asn (rs1805094) polymorphism) are associated with an increased risk of cardiovascular disease. Our pooled analysis revealed an association between the G-2548A (rs12112075) polymorphism and heart disease, high BMI, and obesity. This indicates that individuals carrying the AA allele are at an increased risk for heart disease, high BMI, and obesity. People with heart failure and coronary artery disease did not have the rs7799039 polymorphism or its alleles linked to them.</p><p><strong>Conclusions: </strong>Combined analysis of data from current and published research suggests that the leptin gene polymorphisms G-2548A (rs12112075), rs7799039, and A19G (rs2167270) (but not the Lys656Asn (rs1805094) polymorphism) are associated with an increased risk of cardiovascular disease. Further research is needed to understand this association.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9623460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Decrease in serum asprosin levels following six weeks of spinning and stationary cycling training in overweight women. 超重妇女进行六周动感单车和固定单车训练后血清阿斯凝素水平的降低。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0003
Hossein Nakhaei, Shila Nayebifar, Hamed Fanaei

Objectives: Secreted by white adipose tissue, asprosin is a newly recognized adipokine whose physiological function is not well comprehended. This study intended to determine the effect of spinning and stationary cycling on serum asprosin levels in overweight women.

Methods: Forty-five overweight women with BMI>25 kg/m2 in the age range of 30-40 years were assigned randomly to three groups of 15 participants: control, spinning (group cycling with music), and stationary bike (individual pedaling on a stationary bike). The participants performed the exercises three sessions per week for six weeks. Lipid profile and asprosin levels were measured by enzymatic and ELISA methods, respectively. Moreover, the paired t-test and one-way ANOVA were employed to make within-group and between-group comparisons, respectively.

Results: The stationary cycling and spinning exercise groups experienced significant reductions in weight, BMI, serum triglyceride, and asprosin levels from the pretest to the posttest. The control group showed no statistically significant differences. Serum concentrations of total cholesterol and low-density lipoprotein only declined in the spinning group. In this regard, neither the control group nor the stationary bicycle exhibited no significant change over time. The spinning group demonstrated a significant rise in high-density lipoprotein levels, which was not observed in the control group. In addition, there was no significant difference in WHR index between the intervention groups.

Conclusions: By lowering the serum asprosin level, a spinning exercise program appears to be effective in reducing disorders linked to metabolic diseases in overweight women.

目的:脂肪蛋白是一种新发现的脂肪因子,由白色脂肪组织分泌,其生理功能尚不清楚。本研究旨在确定动感单车和固定单车对超重女性血清阿斯丁蛋白酶水平的影响。方法:将45名年龄在30-40岁、体重指数>25 kg/m2的超重女性随机分为3组,每组15人:对照组、动感单车组(集体骑行伴音乐)和固定单车组(个人在固定单车上蹬车)。参与者每周进行三次锻炼,持续六周。采用酶法和酶联免疫吸附法分别测定脂质谱和血凝蛋白水平。采用配对t检验和单因素方差分析分别进行组内比较和组间比较。结果:从测试前到测试后,固定自行车和动感单车运动组的体重、BMI、血清甘油三酯和阿泌素水平显著降低。对照组差异无统计学意义。血清总胆固醇和低密度脂蛋白浓度仅在旋转组下降。在这方面,无论是对照组还是固定自行车都没有随着时间的推移表现出明显的变化。纺纱组高密度脂蛋白水平显著升高,而对照组未见此现象。此外,干预组之间的WHR指数无显著差异。结论:通过降低血清asprosin水平,动感单车运动项目似乎可以有效地减少超重女性与代谢疾病相关的疾病。
{"title":"Decrease in serum asprosin levels following six weeks of spinning and stationary cycling training in overweight women.","authors":"Hossein Nakhaei,&nbsp;Shila Nayebifar,&nbsp;Hamed Fanaei","doi":"10.1515/hmbci-2022-0003","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0003","url":null,"abstract":"<p><strong>Objectives: </strong>Secreted by white adipose tissue, asprosin is a newly recognized adipokine whose physiological function is not well comprehended. This study intended to determine the effect of spinning and stationary cycling on serum asprosin levels in overweight women.</p><p><strong>Methods: </strong>Forty-five overweight women with BMI>25 kg/m<sup>2</sup> in the age range of 30-40 years were assigned randomly to three groups of 15 participants: control, spinning (group cycling with music), and stationary bike (individual pedaling on a stationary bike). The participants performed the exercises three sessions per week for six weeks. Lipid profile and asprosin levels were measured by enzymatic and ELISA methods, respectively. Moreover, the paired t-test and one-way ANOVA were employed to make within-group and between-group comparisons, respectively.</p><p><strong>Results: </strong>The stationary cycling and spinning exercise groups experienced significant reductions in weight, BMI, serum triglyceride, and asprosin levels from the pretest to the posttest. The control group showed no statistically significant differences. Serum concentrations of total cholesterol and low-density lipoprotein only declined in the spinning group. In this regard, neither the control group nor the stationary bicycle exhibited no significant change over time. The spinning group demonstrated a significant rise in high-density lipoprotein levels, which was not observed in the control group. In addition, there was no significant difference in WHR index between the intervention groups.</p><p><strong>Conclusions: </strong>By lowering the serum asprosin level, a spinning exercise program appears to be effective in reducing disorders linked to metabolic diseases in overweight women.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9578272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Long-term complete remission of metastatic adrenocortical carcinoma. 转移性肾上腺皮质癌的长期完全缓解。
IF 1 Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1515/hmbci-2022-0017
Jersy Cárdenas-Salas, Beatriz Castelo, Rita María Regojo, Juan Antonio González-Sanchez, Cristina Álvarez-Escolá

Objectives: To report a rare case of a metastatic adrenocortical carcinoma (ACC) that achieve a complete and a long-term remission.

Case presentation: AAC is a rare and aggressive tumor, with a high risk of recurrence and that present metastases in 21% of cases at diagnosis. Treatment of advanced ACC is challenging, mitotane is the only available adrenolytic treatment, with modest and unpredictable responses. Response rates to systemic chemotherapy are not encouraging. We describe the case of a 39-year-old woman with a metastatic ACC, that achieve a complete and long-term remission after chemotherapy, mitotane treatment and surgery of primary tumor and liver metastases.

Conclusions: A complete remission of a metastatic adrenocortical carcinoma is possible in some rare cases after a multimodal treatment.

目的:报告一例罕见的转移性肾上腺皮质癌(ACC)获得完全和长期缓解。病例表现:AAC是一种罕见的侵袭性肿瘤,复发风险高,诊断时有21%的病例出现转移。晚期ACC的治疗是具有挑战性的,米托坦是唯一可用的肾上腺素溶解治疗,反应温和且不可预测。对全身化疗的反应率并不令人鼓舞。我们描述了一名39岁的女性转移性ACC的病例,她在化疗、米托坦治疗和原发性肿瘤和肝转移手术后获得了完全和长期的缓解。结论:转移性肾上腺皮质癌的完全缓解是可能的,在一些罕见的情况下,多模式治疗后。
{"title":"Long-term complete remission of metastatic adrenocortical carcinoma.","authors":"Jersy Cárdenas-Salas,&nbsp;Beatriz Castelo,&nbsp;Rita María Regojo,&nbsp;Juan Antonio González-Sanchez,&nbsp;Cristina Álvarez-Escolá","doi":"10.1515/hmbci-2022-0017","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0017","url":null,"abstract":"<p><strong>Objectives: </strong>To report a rare case of a metastatic adrenocortical carcinoma (ACC) that achieve a complete and a long-term remission.</p><p><strong>Case presentation: </strong>AAC is a rare and aggressive tumor, with a high risk of recurrence and that present metastases in 21% of cases at diagnosis. Treatment of advanced ACC is challenging, mitotane is the only available adrenolytic treatment, with modest and unpredictable responses. Response rates to systemic chemotherapy are not encouraging. We describe the case of a 39-year-old woman with a metastatic ACC, that achieve a complete and long-term remission after chemotherapy, mitotane treatment and surgery of primary tumor and liver metastases.</p><p><strong>Conclusions: </strong>A complete remission of a metastatic adrenocortical carcinoma is possible in some rare cases after a multimodal treatment.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9209920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hormone Molecular Biology and Clinical Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1